APA (7th ed.) Citation

R, N., G, F., R, R., A, R., A, V., R, F., . . . LE, A. (2023). Mortality and risk factors of vaccinated and unvaccinated frail patients with COVID-19 treated with anti-SARS-CoV-2 monoclonal antibodies: A real-world study. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 131, 155. https://doi.org/10.1016/j.ijid.2023.03.030

Chicago Style (17th ed.) Citation

R, Nevola, et al. "Mortality and Risk Factors of Vaccinated and Unvaccinated Frail Patients with COVID-19 Treated with Anti-SARS-CoV-2 Monoclonal Antibodies: A Real-world Study." International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases 131 (2023): 155. https://doi.org/10.1016/j.ijid.2023.03.030.

MLA (9th ed.) Citation

R, Nevola, et al. "Mortality and Risk Factors of Vaccinated and Unvaccinated Frail Patients with COVID-19 Treated with Anti-SARS-CoV-2 Monoclonal Antibodies: A Real-world Study." International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases, vol. 131, 2023, p. 155, https://doi.org/10.1016/j.ijid.2023.03.030.